Is the management of diabetes different in dialysis patients?

被引:6
作者
Coelho, Silvia [1 ,2 ]
机构
[1] Hosp Fernando Fonseca, Nephrol & Intens Care Dept, Amadora, Portugal
[2] NOVA Univ Lisbon, NOVA Med Sch, CEDOC Chron Dis Res Ctr, Lisbon, Portugal
关键词
CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; BLOOD-PRESSURE CONTROL; GLYCEMIC CONTROL; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; GLYCATED HEMOGLOBIN; RECEPTOR AGONISTS; LACTIC-ACIDOSIS;
D O I
10.1111/sdi.12698
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Diabetes is highly and increasingly prevalent in the dialysis population and negatively impacts both quality and quantity of life. Nevertheless, the best approach to these patients is still debatable. The question of whether the management of diabetes should be different in dialysis patients does not have a clear yes or no answer but is divided into too many sub-issues that should be carefully considered. In this review, lifestyle, cardiovascular risk, and hyperglycemia management are explored, emphasizing the possible pros and cons of a similar approach to diabetes in dialysis patients compared to the general population.
引用
收藏
页码:367 / 376
页数:10
相关论文
共 99 条
[1]   Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice [J].
Abe, Masanori ;
Okada, Kazuyoshi ;
Soma, Masayoshi .
CURRENT DRUG METABOLISM, 2011, 12 (01) :57-69
[2]   Assessment and Management of Hypertension in Patients on Dialysis [J].
Agarwal, Rajiv ;
Flynn, Joseph ;
Pogue, Velvie ;
Rahman, Mahboob ;
Reisin, Efrain ;
Weir, Matthew R. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (08) :1630-1646
[3]   The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients [J].
Aghamohammadzadeh, Nasser ;
Niafar, Mitra ;
Abdolahinia, Elham Dalir ;
Najafipour, Farzad ;
Gharebaghi, Saeed Mohamadzadeh ;
Adabi, Khadijeh ;
Abdolahinia, Elaheh Dalir ;
Ahadi, Hamidreza .
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (02) :56-60
[4]  
[Anonymous], AM J KIDNEY DIS S1
[5]   Mechanisms of Anemia in CKD [J].
Babitt, Jodie L. ;
Lin, Herbert Y. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10) :1631-1634
[6]   The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial [J].
Baigent, Colin ;
Landray, Martin J. ;
Reith, Christina ;
Emberson, Jonathan ;
Wheeler, David C. ;
Tomson, Charles ;
Wanner, Christoph ;
Krane, Vera ;
Cass, Alan ;
Craig, Jonathan ;
Neal, Bruce ;
Jiang, Lixin ;
Hooi, Lai Seong ;
Levin, Adeera ;
Agodoa, Lawrence ;
Gaziano, Mike ;
Kasiske, Bertram ;
Walker, Robert ;
Massy, Ziad A. ;
Feldt-Rasmussen, Bo ;
Krairittichai, Udom ;
Ophascharoensuk, Vuddidhej ;
Fellstrom, Bengt ;
Holdaas, Hallvard ;
Tesar, Vladimir ;
Wiecek, Andrzej ;
Grobbee, Diederick ;
de Zeeuw, Dick ;
Gronhagen-Riska, Carola ;
Dasgupta, Tanaji ;
Lewis, David ;
Herrington, William ;
Mafham, Marion ;
Majoni, William ;
Wallendszus, Karl ;
Grimm, Richard ;
Pedersen, Terje ;
Tobert, Jonathan ;
Armitage, Jane ;
Baxter, Alex ;
Bray, Christopher ;
Chen, Yiping ;
Chen, Zhengming ;
Hill, Michael ;
Knott, Carol ;
Parish, Sarah ;
Simpson, David ;
Sleight, Peter ;
Young, Alan ;
Collins, Rory .
LANCET, 2011, 377 (9784) :2181-2192
[7]   Drug therapy - Metformin [J].
Bailey, CJ ;
Turner, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579
[8]   Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) [J].
Bilo, Henk ;
Coentrao, Luis ;
Couchoud, Cecile ;
Covic, Adrian ;
De Sutter, Johan ;
Drechsler, Christiane ;
Gnudi, Luigi ;
Goldsmith, David ;
Heaf, James ;
Heimburger, Olof ;
Jager, Kitty J. ;
Nacak, Hakan ;
Jose Soler, Maria ;
Van Huffel, Liesbeth ;
Tomson, Charlie ;
Van Laecke, Steven ;
Weekers, Laurent ;
Wiecek, Andrzej ;
Bolignano, Davide ;
Haller, Maria ;
Nagler, Evi ;
Nistor, Ionut ;
van der Veer, Sabine ;
Van Biesen, Wim .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 :1-142
[9]   K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients [J].
Bolton, K ;
Beddhu, S ;
Campese, VM ;
Chavers, BM ;
Cheung, AK ;
Churchill, DN ;
Goldstein-Fuchs, J ;
Herzog, CA ;
Henrich, W ;
King, K ;
Kronenberg, F ;
Miholics, BS ;
Painter, PL ;
Parekh, R ;
Roberts, MS ;
Stehman-Breen, C ;
Stenvinkel, P ;
Wali, R ;
Weiss, MF .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (04) :S7-S153
[10]   Insulin secretagogues, sulfonylurea receptors and KATP channels [J].
Bryan, J ;
Vila-Carriles, WH ;
Babenko, AP ;
Aguilar-Bryan, L .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (21) :2699-2716